B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 4 610 KRW 1.32% Market Closed
Market Cap: 262.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
BioPlus Co Ltd

There are no price targets for BioPlus Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioPlus Co Ltd Competitors:
Price Targets
TOPGLOV
Top Glove Corporation Bhd
1% Downside
SUPERMX
Supermax Corporation Bhd
10% Upside
NEOG
Neogen Corp
31% Upside
605369
Zhejiang Gongdong Medical Technology Co Ltd
62% Upside
STAA
STAAR Surgical Co
85% Upside
1501
Shanghai Kindly Medical Instruments Co Ltd
28% Upside
RXST
Rxsight Inc
50% Upside
ESTA
Establishment Labs Holdings Inc
78% Upside

Revenue
Forecast

Revenue Estimate
BioPlus Co Ltd

For the last 4 years the compound annual growth rate for BioPlus Co Ltd's revenue is 40%. The projected CAGR for the next 2 years is 43%.

40%
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
BioPlus Co Ltd

For the last 4 years the compound annual growth rate for BioPlus Co Ltd's operating income is 42%. The projected CAGR for the next 2 years is 51%.

42%
Past Growth
51%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
BioPlus Co Ltd

For the last 4 years the compound annual growth rate for BioPlus Co Ltd's net income is 46%. The projected CAGR for the next 2 years is 33%.

46%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BioPlus Co Ltd's stock price target?
Not Available

BioPlus Co Ltd doesn't have any price targets made by Wall Street professionals.

What is BioPlus Co Ltd's Revenue forecast?
Projected CAGR
43%

For the last 4 years the compound annual growth rate for BioPlus Co Ltd's revenue is 40%. The projected CAGR for the next 2 years is 43%.

What is BioPlus Co Ltd's Operating Income forecast?
Projected CAGR
51%

For the last 4 years the compound annual growth rate for BioPlus Co Ltd's operating income is 42%. The projected CAGR for the next 2 years is 51%.

What is BioPlus Co Ltd's Net Income forecast?
Projected CAGR
33%

For the last 4 years the compound annual growth rate for BioPlus Co Ltd's net income is 46%. The projected CAGR for the next 2 years is 33%.

Back to Top